We have examined the hypothesis that the severe congenital form of myotonic dystrophy is caused by genomic imprinting at the level of differential DNA methylation of maternal and paternal alleles. Probes encompassing the 5', central, and 3' regions of the myotonic dystrophy protein kinase gene were used on blots of blood DNA from congenital and adult onset patients, digested with combinations of methylation sensitive and insensitive restriction enzymes. We observed similar patterns of methylation in each of the different classes of patient, and found no methylation differences between paternally and maternally derived alleles. Within the limitations of the experiment, our results provide no evidence for a role for genomic imprinting in congenital myotonic dystrophy and suggest that the explanation for this form of the disease will be found elsewhere. (J Med Genet 1993;30:189-92) 
Myotonic dystrophy (DM) is one of the commonest inherited neuromuscular disorders, and shows autosomal dominant inheritance with highly variable expression and a wide range of symptoms. In DM families, it is commonly observed that the severity of the symptoms increases with each successive generation, and the age at onset decreases similarly. This phenomenon is termed anticipation. A particularly severe congenital form of the disease may occur in affected infants born to affected mothers (but never when the father is the affected parent). For a review of the disease in general, see Harper. ' We and others have recently identified the mutation causing DM and the gene that is affected. Linkage studies had mapped the locus to l9q13.321 and linkage disequilibrium analysis predicted that most cases would have a common mutational origin.5 Extensive analysis using probes derived from the DM candidate region identified a DNA fragment that expanded in size in DM families, and showed that this expansion was exclusively associated with the DM phenotype.*5 Further investigation showed that the expansion was the result of an unstable tandemly repeated CTG sequence, located in the 3' untranslated region of a protein kinase family gene.9'0 Progressive expansion of this sequence in generations of a DM family was correlated with increasing disease severity and earlier age at onset, and hence provided a biological basis for anticipation.67" An analogous mechanism had already been described in the fragile X syndrome, in this case an unstable CCG repeat sequence in the 5' untranslated region of a gene designated Patients with congenital myotonic dystrophy (CDM) have DNA expansions of between 1-5 and 6 kb."' 13 Although this is larger on average than the expansions seen in non-congenital, adult onset or minimal forms of DM, there is considerable overlap between the size ranges of DNA expansion in the various disease classes." 13 Therefore DNA expansion alone is not sufficient to explain the congenital form of DM, nor why it is exclusively maternally transmitted.
Genomic imprinting is a process whereby the maternal and paternal genetic contributions to the offspring are expressed differently, and has been studied extensively in the mouse.'4 By using transgenic animals it was shown that imprinting effects are strongly correlated with DNA methylation.'5 It has been suggested'6 that imprinting might account for the fact that the congenital form of DM is exclusively maternally transmitted. If the paternally derived normal allele of the DM gene were inactivated by methylation, and the mother's allele was mutated, then the offspring might be expected to show a particularly severe form of the disease. Before the discovery of the mutation in fragile X syndrome, it had been shown that DNA methylation at a specific site in Xq27.3 was associated with clinically affected subjects'7 and it is now known that this site is an HTF island at the 5' end of the FMR-1 gene.'8 The island is hypermethylated in males affected with the fragile X syndrome and on the fragile X chromosome of female carriers. In general the degree of methylation is positively correlated with the degree of length expansion of the fragile X CCG repeat sequence. It is not known whether methylation directly affects the expression of the FMR-1 gene, or whether it is merely a consequence of the mutation. '9 In order to investigate whether genomic imprinting at the level of DNA methylation might have a role in the congenital form of myotonic dystrophy, we used sequences from within and around the DM protein kinase gene to probe Southern blots of DNA digested with methylation sensitive restriction enzymes, in combination with enzymes detecting DNA polymorphisms that allow the parental origin of the alleles to be distinguished. If there were differences in methylation between the maternally and paternally derived alleles in DM patients, these should be detectable using such an approach. were taken from blood cells of relatively mature persons. In the case of congenital myotonic dystrophy patients, the samples would have been taken at a time when the patient was no longer affected with this form of the disease. It is possible that methylation may play a role at a stage of development, or in a particular tissue, that was not accessible to this study. For example, the development of the congenital form might be influenced by genomic imprinting in utero, with subsequent loss of the imprint after birth. For obvious practical reasons it would be hard to investigate this hypothesis extensively, although investigation of the DNA of congenitally affected infants who unfortunately died in the perinatal period, or of chorionic villus DNA of pregnancies predicted to end in a congenitally affected child, could be tried. In fragile X it has been shown that the characteristic methylation of the FMR-1 gene HTF island is present in fetal tissue but not in chorionic villus.22 A second gene (designated 59) has been found to lie very close to the myotonic dystrophy protein kinase locus, and its equivalent in the mouse was characterised recently.20 In the present study we used a probe that identifies the region containing the 5' end of the kinase gene and the 3' end of the 59 gene, which have been shown by DNA sequencing to be less than 500 bp apart (Shaw et al, submitted). A role for the 59 gene in the pathology of myotonic dystrophy has yet to be established, but if this gene is important in the disease it will be of interest to study the methylation of its 5' regions in the same way as has been done in the present study.
There is still no satisfactory explanation for the congenital form of myotonic dystrophy. It appears likely that the mother's degree of severity (which is related to the size of DNA expansion) plays a part, since generally speaking only mothers with overt muscle symptoms are at risk for congenitally affected offspring.23
Thus there appears to be an interaction between the genotypes of the mother and offspring, which might be mediated, for example, by a transplacental factor or by the physiological state of the uterus. We are presently investigating the precise relationship between the extent of DNA expansion in the DM alleles of parents and offspring, the expression of the protein kinase and 59 genes, and the development of the congenital form of the disease. 
